RCM
PBYI icon

Raptor Capital Management’s Puma Biotechnology PBYI Stock Holding History

Raptor Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-85,712
Closed -$3.8M – 50
2013
Q2 		$3.8M Buy
+85,712
New +$3.02M 2.02% 18

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Raptor Capital Management's PBYI Position: Q3 2013 in Review

Raptor Capital Management sold out of Puma Biotechnology (PBYI) in Q3 2013, closing a stake of 85,712 shares — an estimated $3.8M sold.

Raptor Capital Management first reported a position in PBYI in Q2 2013 and held it in 1 quarter. The position peaked at $3.8M in Q2 2013. 92 funds tracked by Wall St. Rank hold PBYI as of Q3 2013.

  • Raptor Capital Management reported no remaining Puma Biotechnology position as of Q3 2013 after selling out during the quarter.
  • Raptor Capital Management sold 85,712 Puma Biotechnology shares in Q3 2013, an estimated $3.8M.
  • Raptor Capital Management first reported a position in Puma Biotechnology in Q2 2013 and held it in 1 quarter.
  • Raptor Capital Management's Puma Biotechnology position peaked at $3.8M in Q2 2013.
  • 92 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2013.

Based on Raptor Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.